We are excited to announce that GemPharmatech will be attending the Society for Neuroscience 2023 annual meeting in Washington, D.C. from November 11th - 15th, 2023. Stop by our booth (#1602) to meet our team members and learn more about our neurodegenerative disease models.

Join us for a symposium presentation entitled: “The GPT hSOD1 G93A mouse model can replicate progressive ALS-like phenotypes” on Wednesday, November 15th, from 8:45 AM to 9:00 AM (EST) at WCC 152B!

During this event, be sure to attend our poster presentations:

Poster 1: PSTR016.18 / K2 - The Role of Different SNCA Mutations in Parkinson’s Disease as Revealed by Comparing Two Mouse Models

Date: November 11, 2023

Time: 1:00 PM - 5:00 PM

Location: WCC Halls A-C

Poster 2: PSTR532.04 / P3 - B6-hHTT130-N: An Improved Mouse Model for Drug Efficacy Screening and Therapeutic Development for Huntington Disease

Date: November 15, 2023

Time: 1:00 PM - 5:00 PM

Location: WCC Halls A-C

As the leading provider of genetically modified mouse models and preclinical services, GemPharmatech understands the importance of developments in the field of neuroscience. We have established many disease-related mouse models to address neurodegenerative diseases, including Alzheimer's Disease (AD), Parkinson’s Disease (PD), and rare diseases such as Huntington's Disease (HD), Amyotrophic Lateral Sclerosis (ALS), and Duchenne Muscular Dystrophy (DMD). In addition, we provide a comprehensive platform of behavioral testing services.

We look forward to meeting you at the conference!

To learn more, please visit their website.